title: [Myoinositol--alternative treatment of insulin resistance in adolescents].
abstract: Myo-inostitol is a part of inositolphosphoglycan (IPG) mediators, which are known as putative mediators of insulin. One of the theories for insulin resistance is any deficiency in Myo-inositol. Presumably a substitution therapy with exogenous Myo-inositol could be effective for treatment of insulin resistance and PCOS. This is well established in women in reproductive age, but there is insufficient data for adolescence.
authors.forename: S
authors.initials: S
authors.lastname: Kedikova
authors.forename: M
authors.initials: M
authors.lastname: Sirakov
authors.forename: M
authors.initials: M
authors.lastname: Boyadzhieva
mesh_terms: D000293:Adolescent; D005260:Female; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D007295:Inositol Phosphates / Q000378:metabolism; D007328:Insulin / Q000378:metabolism*; D007333:Insulin Resistance; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy; D011134:Polysaccharides / Q000378:metabolism
chemical_list: D007295:Inositol Phosphates; D007328:Insulin; D011134:Polysaccharides; C028039:inositol phosphate glycan; D007294:Inositol